Twitter | Search | |
HEPATOLOGY Journal
HEPATOLOGY: Official journal of AASLD () covering liver diseases, hepatitis, cancer, cirrhosis, drug metabolism, and immunology
2,584
Tweets
472
Following
10,200
Followers
Tweets
HEPATOLOGY Journal retweeted
Russell Rosenblatt Sep 16
Early HCV treatment in kidney and liver transplant patients. Let's do it!
Reply Retweet Like
HEPATOLOGY Journal Sep 16
Important review on addressing in important populations where there can be benefits, impact on future generations and those at high risk for progression 🔑Children and adolescents 🔑Future parents 🔑Postmenopausal women
Reply Retweet Like
HEPATOLOGY Journal retweeted
Henry E. Chang Sep 15
Prospective multi-center study of early antiviral therapy in & transplant recipients of viremic donors→ via
Reply Retweet Like
HEPATOLOGY Journal retweeted
Atoosa Rabiee Sep 11
✔️Take the time ✔️Ask patients to bring medication bottles to visits ✔️Provide simplified written instructions/flash cards ✔️Dedicated nurse/pharmacy visit to review medications
Reply Retweet Like
HEPATOLOGY Journal retweeted
Lizzie Aby, MD Sep 11
Great work by et al in Hepatology 👇 ▪️Those w/decompensated cirrhosis are ⛔️ filling indicated medications as often or as long as is recommended ▪️But they are filling medications that are potentially harmful 💊
Reply Retweet Like
HEPATOLOGY Journal retweeted
Atoosa Rabiee Sep 1
🔔Does treatment response in AKI-HRS affect post LT outcomes? 📌Non‐responders-> ⬆️incidence of CKD @ 1year post 📌non‐response to terlipressin➕ albumin-> independent predictor for CKD @ 1year post LT 📌responders -> ⬆️wait/⬇️MELD
Reply Retweet Like
HEPATOLOGY Journal retweeted
AASLD Sep 1
From : "Attributable Fractions of for Mortality in the United States: Results From the Third National Health and Nutrition Examination Survey With 27 Years of Follow‐up"
Reply Retweet Like
HEPATOLOGY Journal retweeted
AASLD Aug 31
Register for the "Global Public Health Strategies for the Prevention of in 2020" webinar on Tuesday, September 1 at 12 pm ET. Presenter: Moderators: Learn more & register 👉
Reply Retweet Like
HEPATOLOGY Journal retweeted
Juan Pablo Arab, MD Aug 27
Reply Retweet Like
HEPATOLOGY Journal Aug 31
Genome-wide association study and meta-analysis identifies genetic variants that underlie risk for -related - see the author’s summary below!
Reply Retweet Like
HEPATOLOGY Journal retweeted
AASLD Aug 24
From : "Maintaining Patient Safety and Data Integrity of Clinical Trials During the SARS‐CoV‐2 Pandemic"
Reply Retweet Like
HEPATOLOGY Journal retweeted
Howard T. Lee MD Aug 23
RCT re TEG guided transfusion in cirrhosis pt w/ non-variceal bleeding 👇 🔹n=96 (49 TEG/47 SOC), INR >1.8, plt <50K 🔹⬇️use of🩸(FFP, PLT, cyro) in TEG group 🔹Similar rate of failure control/prevent bleeding & mortality 📚
Reply Retweet Like
HEPATOLOGY Journal Aug 22
A 3 pronged platform (TriVac) to enhance adaptive immunity for cancer
Reply Retweet Like
HEPATOLOGY Journal Aug 21
Multiple roles for and and the host in the development of
Reply Retweet Like
HEPATOLOGY Journal retweeted
AASLD Aug 18
From : "Efficacy and Safety of Immunosuppression Withdrawal in Pediatric Liver Transplant Recipients: Moving Towards Personalized Management"
Reply Retweet Like
HEPATOLOGY Journal Aug 19
HBV-specific ImmTAV-Env, a soluble bispecific T cell receptor, enables elimination of + cells by redirection and activation of polyclonal T cells
Reply Retweet Like
HEPATOLOGY Journal retweeted
Russell Rosenblatt Aug 17
Strong work as always by ! One question that's always tough is - Can my patient drive? Look to for that answer. Here's an oldie but a goodie from .
Reply Retweet Like
HEPATOLOGY Journal retweeted
ClinicalLiverDisease Apr 15
Reply Retweet Like
HEPATOLOGY Journal Aug 17
Phase 2 study by et al: effect of Aldafermin ( analog) on ✳️ Pts with biopsy confirmed + + elevated liver fat ✳️ 12 weeks of drug vs placebo ✳️ Aldafermin cohort had ⬆️Veillonella correlating w/ ⬇️bile acids
Reply Retweet Like
HEPATOLOGY Journal Aug 7
Phase1 trial by et al demonstrates that may help in patients with alcohol related and use disorder
Reply Retweet Like